(Press-News.org) Long-term follow-up of a phase II study from KEMRI-Wellcome Trust Research Programme and Oxford University researchers in Kenya shows that the efficacy of a malaria vaccine candidate, RTS,S, wanes over time and varies with exposure to the malaria parasite.
The findings will help to inform which populations are likely to benefit most from the vaccine candidate. They also have important implications for the design of future clinical trials of this and other vaccine candidates and highlight the importance of long-term follow-up studies for assessing vaccine efficacy.
The study involved 447 children in Kilifi, Kenya, who had been part of an earlier phase II trial to assess the safety and efficacy of the vaccine candidate. Of the 447 children, 320 completed four years of follow-up. The analysis, which was published today in the 'New England Journal of Medicine', was designed to look at how well the vaccine candidate protects against malaria over time.
Initial results from larger ongoing phase III studies showed that the candidate RTS,S vaccine reduced malaria over 12 months of follow-up by approximately half in young children and one-third in infants. The new findings on long-term follow-up of an earlier phase II study reveal that the vaccine efficacy dropped from 43.6 per cent protection against malaria in the first year to zero by the fourth year after vaccination.
The study's senior author, Dr Phillip Bejon (Research Fellow at the KEMRI-Wellcome Trust Research Programme and the Centre for Tropical Medicine, University of Oxford), said: "Despite the falling efficacy over time, there is still a clear benefit to the vaccine candidate. Many of the children will experience multiple episodes of clinical malaria infection, but overall we found that 65 cases of malaria were averted over the four-year period for every 100 children vaccinated. We now need to look at whether offering a vaccine booster can sustain efficacy for longer."
The study also shows that relative vaccine efficacy declines with increasing exposure to malaria, from 45.1 per cent among children with below-average exposure to malaria to 15.9 per cent among children with above-average exposure to malaria. The relative efficacy describes the number of cases of malaria that were avoided by vaccination as a percentage of the total number of cases in that group: because there were many more cases of malaria at higher exposure, the cases averted per 100 children vaccinated actually increased from 62 at below-average exposure to 78 at above-average exposure.
The study's lead author, Dr Ally Olotu, a Wellcome Trust PhD student at the KEMRI-Wellcome Trust Research Programme and Oxford University, explains: "We need to consider whether relative efficacy or absolute number of cases averted is the more informative measure. In any case, these are important findings that will help to inform which populations are likely to benefit most from the vaccine.
"The ongoing phase III study will provide further insights to the vaccine's efficacy in different settings of malaria exposure and includes an assessment of a booster dose to sustain efficacy over time."
Malaria remains an important cause of illness and death among children in sub-Saharan Africa, and there is currently no vaccine that offers complete protection against the disease. RTS,S is the most advanced candidate malaria vaccine and entered phase III clinical trials in Africa in 2009. The vaccine candidate seems to be well tolerated and has an acceptable safety profile, but it remains unclear which sub-groups of children might benefit most and what the duration of efficacy is.
Jimmy Whitworth, Head of International Activities at the Wellcome Trust, said: "This study indicates the durability of protection of a single initial course of this vaccine against malaria, and the variability of protection at different levels of exposure to malaria. These are key pieces of information required for us to understand how best to use this vaccine and the regimes of boosters that will be required to provide optimum protection."
Latest figures estimate that there are 1.44 billion people living in regions of stable malaria transmission worldwide. Most deaths occur among children living in Africa, where a child dies from malaria every minute.
### END
Follow-up study describes declining efficacy of malaria vaccine candidate over 4 years
2013-03-21
ELSE PRESS RELEASES FROM THIS DATE:
New hope to beat malaria once and for all
2013-03-21
"The 4(1H)-quinolone-3- diarylethers are selective potent inhibitors of the parasite mitochondrial cytochrome bc1 complex," Professor Avery said.
"These compounds are highly active against the types of malaria parasites which infect humans, Plasmodium falciparum and Plasmodium vivax," she said.
"What is really exciting about this study is that a new class of drugs based on the 4(1H)-quinolone-3- diarylethers would target the malaria parasite at different stages of its lifecycle."
This provides the potential to not only kill the parasite in people who are infected, ...
97 percent of UK doctors have given placebos to patients at least once
2013-03-21
A survey of UK doctors found that 97% have prescribed placebo treatments to patients at least once in their career.
Researchers at the Universities of Oxford and Southampton in the UK discovered that 97% of doctors have used 'impure' placebo treatments, while 12% have used 'pure' placebos.
'Impure' placebos are treatments that are unproven, such as antibiotics for suspected viral infections, or more commonly non-essential physical examinations and blood tests performed to reassure patients. 'Pure' placebos are treatments such as sugar pills or saline injections which ...
Women abused as children more likely to have children with autism
2013-03-21
Boston, MA — Women who experienced physical, emotional, or sexual abuse as children are more likely to have a child with autism than women who were not abused, according to a new study from Harvard School of Public Health (HSPH). Those who experienced the most serious abuse had the highest likelihood of having a child with autism — three-and-a-half times more than women who were not abused.
"Our study identifies a completely new risk factor for autism," said lead author Andrea Roberts, research associate in the HSPH Department of Social and Behavioral Sciences. "Further ...
Scripps scientists discover 'lubricant' for Earth's tectonic plates
2013-03-21
Scientists at Scripps Institution of Oceanography at UC San Diego have found a layer of liquefied molten rock in Earth's mantle that may be acting as a lubricant for the sliding motions of the planet's massive tectonic plates. The discovery may carry far-reaching implications, from solving basic geological functions of the planet to a better understanding of volcanism and earthquakes.
The scientists discovered the magma layer at the Middle America trench offshore Nicaragua. Using advanced seafloor electromagnetic imaging technology pioneered at Scripps, the scientists ...
Stem cells entering heart can be tracked with nano-'hitchhikers,' Stanford scientists say
2013-03-21
STANFORD, Calif. — The promise of repairing damaged hearts through regenerative medicine — infusing stem cells into the heart in the hope that these cells will replace worn out or damaged tissue — has yet to meet with clinical success. But a highly sensitive visualization technique developed by Stanford University School of Medicine scientists may help speed that promise's realization.
The technique is described in a study to be published March 20 in Science Translational Medicine. Testing the new imaging method in humans is probably three to five years off.
Human and ...
University of South Florida researchers play key role in discovery of new drug to combat malaria
2013-03-21
Tampa, FL (March 20, 2013) -- University of South Florida researchers played a key role in an international multidisciplinary project that has yielded a promising new antimalarial drug with the potential to cure the mosquito-borne disease and block its transmission with low doses.
Roman Manetsch, PhD, USF associate professor of chemistry, and Dennis Kyle, PhD, USF professor of global health, were co-leaders of the USF team, which helped to discover and develop a series of potent compounds to combat malaria known as the 4-(1H)-quinolone-3-diarylethers, or quinolones.
The ...
Expression of emotion in books declined during 20th century, study finds
2013-03-21
The use of words with emotional content in books has steadily decreased throughout the last century, according to new research from the Universities of Bristol, Sheffield, and Durham. The study, published today in PLOS ONE, also found a divergence between American and British English, with the former being more 'emotional' than the latter.
The researchers looked at how frequently 'mood' words were used through time in a database of more than five million digitised books provided by Google. The list of words was divided into six categories (anger, disgust, fear, joy, ...
Roads could help rather than harm the environment, say experts
2013-03-21
Two leading ecologists say a rapid proliferation of roads across the planet is causing irreparable damage to nature, but properly planned roads could actually help the environment.
"Loggers, miners and other road builders are putting roads almost everywhere, including places they simply shouldn't go, such as wilderness areas," said Professor Andrew Balmford of the University of Cambridge, UK. "Some of these roads are causing environmental disasters."
"The current situation is largely chaos," said Professor William Laurance of James Cook University in Cairns, Australia. ...
Older grandfathers pass on autism risk through generations
2013-03-21
Men who have children at older ages are more likely to have grandchildren with autism compared to younger grandfathers, according to new research. This is the first time that research has shown that risk factors for autism may accumulate over generations.
The study led by King's College London's Institute of Psychiatry, Karolinska Institutet in Sweden and the Queensland Brain Institute in Australia is published today in JAMA Psychiatry.
By using Swedish national registers, researchers identified 5,936 individuals with autism and 30,923 healthy controls born in Sweden ...
UNC study shows how 2 brain areas interact to trigger divergent emotional behaviors
2013-03-21
(Embargoed) CHAPEL HILL, N.C. – New research from the University of North Carolina School of Medicine for the first time explains exactly how two brain regions interact to promote emotionally motivated behaviors associated with anxiety and reward.
The findings could lead to new mental health therapies for disorders such as addiction, anxiety, and depression. A report of the research was published online by the journal, Nature, on March 20, 2013.
Located deep in the brain's temporal lobe are tightly packed clusters of brain cells in the almond shaped amygdala that are ...